Cargando…
Sirolimus Adverse Event Profile in a Non-Clinical Trial Cohort of Heart Transplantation Patients
BACKGROUND: Sirolimus has been used increasingly in heart transplantation for its ability to reduce acute rejection, prevent the progression of cardiac allograft vasculopathy (CAV), and preserve renal function. We sought to assess the adverse reactions associated with the use of sirolimus compared t...
Autores principales: | Sallam, Karim, Bhumireddy, Geetha P., Evuri, Vishnu D., Abella, Joshua P., Haddad, Francois, Valantine, Hannah A., Nguyen, Patricia K., Pham, Michael X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824988/ https://www.ncbi.nlm.nih.gov/pubmed/33462174 http://dx.doi.org/10.12659/AOT.923536 |
Ejemplares similares
-
Nanomedicines in renal transplant rejection – focus on sirolimus
por: Shen, Li-Jiuan, et al.
Publicado: (2007) -
Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017) -
Sirolimus in renal transplant recipients with malignancies in Germany
por: Naik, Marcel G, et al.
Publicado: (2020) -
Hemopericardium in a Sirolimus-Treated Renal Transplant Patient
por: Groudan, Kevin, et al.
Publicado: (2020) -
Sirolimus-Induced Rash in a Kidney Transplant Patient
por: Bruss, Zachary, et al.
Publicado: (2022)